Hospital Stocks: Big Opportunity or Too Expensive?

India’s hospital sector is entering a major expansion phase, supported by rising healthcare demand, increasing insurance penetration, medical tourism, improving ARPOBs and large-scale capacity additions. In this discussion, we break down the Indian hospital industry from an investor’s perspective — including key growth drivers, business models, bed capacity, occupancy, ARPOB, margins, capex plans, expansion strategies and major risks. We also discuss leading hospital companies such as Apollo Hospitals, Max Healthcare, Fortis Healthcare, Narayana Health, KIMS, Medanta, Yatharth, Artemis and others, while comparing how different players are positioned for the next phase of industry growth. The discussion also looks at an important question: while the hospital sector has strong structural growth potential, are current valuations already pricing in too much optimism? Watch the complete discussion for a detailed understanding of India’s evolving hospital sector. #HospitalSector #HospitalStocks #healthcaresector #healthcarestocks #indianhealthcare #HospitalIndustry #apollohospitals #maxhealthcare #fortishealthcare #narayanahealth #kimshospitals #medantahospital #healthcareinvesting #indianstockmarket #equityresearch 00:00 Start 02:28 Industry 08:43 Business Model 13:43 Apollo Hospital 15:36 Max Healthcare 18:19 Manipal Hospitals 21:22 Fortis Healthcare 23:35 Aster DM 26:36 Global Health (Medanta) 29:14 Narayana Hrudayalaya 31:38 Kims Hospital 34:58 Dr. Agarwal's Health Care 37:18 Yarharth Hospital 40:43 Bed capacity comparison 42:05 FY26 Results Comparison Research Based Ready-made Model Portfolios: https://investyadnya.in/model-portfolios Yadnya Books and eBooks now available: On Amazon - https://amzn.to/47x0RS4 On Flipkart - https://fktr.in/y3OZ3GF On our website - https://shop.investyadnya.in Find us on Social Media and stay connected: Whatsapp Channel - https://whatsapp.com/channel/0029Va6N... Blog - https://blog.investyadnya.in Telegram - http://t.me/InvestYadnya Facebook Page -   / investyadnya   Twitter -   / investyadnya   LEGAL DISCLAIMER: Use of this information is at the user's own risk. The Company and its directors, associates and employees will not be liable for any loss or liability incurred to the user due to investments made or decisions taken based on the information provided herein. The investment discussed or views expressed herein may not be suitable for all investors. The users should rely on their own research and analysis and should consult their investment advisors to determine the merit, risks and suitability of recommendation. Past performance is not a guarantee for future performance or future results. Information herein is believed to be reliable, although its accuracy and completeness cannot be guaranteed. The images used may be copyright of the company or third party. As a condition to using the services, the user agrees to the terms of use of the website and the services. DISCLOSURES UNDER SEBI (RESEARCH ANALYST) REGULATIONS, 2014: Yadnya Academy Pvt. Ltd. (InvestYadnya) is registered with SEBI under SEBI (Research Analyst) Regulations, 2014 with registration no. INH000008349. Disclosure with regard to ownership and material conflicts of interest 1. Neither Research Analyst nor the entity nor his associates or relatives have any financial interest in the subject Company; 2. Neither Research Analyst nor the entity nor its associates or relatives have actual / beneficial ownership of one per cent or more securities of the subject Company, at the end of the month immediately preceding the date of publication of the research report or date of public appearance; 3. Neither Research Analyst nor the entity nor its associates or his relatives have any other material conflict of interest at the time of publication of the research report or at the time of public appearance. Disclosure with regard to receipt of Compensation 1. The Research Entity and its associates have not received compensation from the subject company in the past twelve months. 2. The subject company is not or was not a client during the twelve months preceding the date of recommendation.